Collaborative Supply Chain Management In A Fragmented World

By John Clarke

Supply chain resilience in biopharma is advancing, but mounting geopolitical pressures are reshaping what stability looks like. With 76% of industry leaders anticipating tariffs and trade barriers to disrupt sourcing strategies, familiar cost-driven models are no longer enough. Fragmentation is accelerating regionalization, leading to revalidation challenges, rising costs, and increasingly complex regulatory expectations. Research budgets are tightening as organizations navigate these shifts, while collaboration across the US, Europe, and China becomes more constrained. In this environment, resilience depends less on efficiency alone and more on agility, trust, and deeper strategic partnerships.

Access the full article to learn how organizations that rethink risk and embrace more adaptive, collaborative approaches will be better positioned to navigate uncertainty and sustain innovation.